Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture

Biochemical Journal

Volumn 384, Issue 2, 2004, Pages 271-279

  Mitchell, John L A ^a   Simkus, Carrie L ^a   Thane, Thynn K ^a   Tokarz, Phil ^a   Bonar, Michelle M ^a   Frydman, Benjamin ^b   Valasinas, Aldonia L ^b   Reddy, Venodhar K ^b   Marton, Laurence J ^b,c  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b SLIL Biomedical Corp   (United States)

^c Cellgate Incorporated   (United States)

Author keywords

Antizyme; Antizyme inhibitor; Bis(ethyl)polyamine; Oligoamine; Polyamine analogue; Polyamine transport

Indexed keywords

AMINES; CELLS; TUMORS;

ANTIZYME INDUCTION; CELL PROLIFERATION;

BIOCHEMISTRY;

ANTIZYME; POLYAMINE DERIVATIVE; SPERMINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EXPOSURE; FEEDBACK SYSTEM; FEMALE; GENETIC TRANSFECTION; HEPATOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SAMPLING; STEADY STATE; TISSUE CULTURE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FEEDBACK, BIOCHEMICAL; LIVER NEOPLASMS, EXPERIMENTAL; POLYAMINES; PROTEINS; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 10644276015     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20040972     Document Type: Article

References (58)

1. Cohen, S. S. (1998) A guide to the polyamides. Oxford University Press, Oxford
2. Manni, A., Grove, R., Kunselman, S. and Aldaz, M. (1995) Involvement of the polyamine pathway in breast cancer progression. Cancer Lett. 92, 49-57
3. Pegg, A. E., Shantz, L. M. and Coleman, C. S. (1995) Ornithine decarboxylase as a target for chemoprevention. J. Cell. Biochem. (suppl.) 22, 132-138
4. Marton, L. J. and Pegg, A. E. (1995) Polyamines as targets for therapeutic intervention. Annu. Rev. Pharm. Toxicol. 35, 55-91
5. Kubota, S. (1998) Ornithine decarboxylase and cancer. Cancer J. 11, 294-297
6. Wallace, H. M., Fraser, A. V. and Hughes, A. (2003) A perspective of polyamine metabolism. Biochem. J. 376, 1-14
7. Khan, N. A., Quemener, V. and Moulinoux, J.-P. (1994) Characterization of polyamine transport pathways. In Neuropharmacology of Polyamines (Carter, C., ed.), pp. 37-60, Academic Press Limited, London
8. Seiler, N., Delcros, J. G. and Moulinoux, J. P. (1996) Polyamine transport in mammalian cells - an update. Int. J. Biochem. Cell Biol. 28, 843-861
9. Seiler, N., Atanassov, C. L. and Raul, F. (1998) Polyamine metabolism as target for cancer chemoprevention. Int. J. Oncology 13, 993-1006
10. Kramer, D. L. (1996) Polyamine inhibitors and analogs. In Polyamines in Cancer: Basic Mechanisms and Clinical Approaches (Nishioka, K., ed.), pp. 151-189, R. G. Landes Company, Austin
11. Porter, C. W., McManis, J., Casero, R. A. and Bergeron, R. J. (1987) Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth. Cancer Res. 47, 2821-2825
12. Wallace, H. M. and Fraser, A. V. (2003) Polyamine analogues as anticancer drugs. Biochem. Soc. Trans. 31, 393-396
13. Porter, C. W. and Sufrin, J. R. (1986) Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res. 6, 525-542
14. Casero, R. A. and Woster, P. M. (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44, 1-26
15. Kramer, D. L., Fogelpetrovic, M., Diegelman, P., Cooley, J. M., Bernacki, R. J., McManis, J. S., Bergeron, R. J. and Porter, C. W. (1997) Effects of novel spermine analogues on cell cycle progression and apoptosis in malme-3m human melanoma cells. Cancer Res. 57, 5521-5527
16. Reddy, V. K., Valasinas, A., Sarkar, A., Basu, H. S., Marton, L. J. and Frydman, B. (1998) Conformationally restricted analogues of n-1 ,n-12-bisethylspermine - synthesis and growth inhibitory effects on human tumor cell lines. J. Med. Chem. 41, 4723-4732
17. Saab, N. H., West, E. E., Bieszk, N. C., Preuss, C. V., Mank, A. R., Casero, R. A. and Woster, P. M. (1993) Synthesis and evaluation of unsymmetrically substituted polyamine analogues as modulators of human spermidine spermine-N1-acetyltransferase (SSAT) and as potential antitumor agents. J. Med. Chem. 36, 2998-3004
18. Gabrielson, E. W., Pegg, A. E. and Casero, R. A. (1999) The induction of spermidine/spermine N-1-acetyltransferase (SSAT) is a common event in the response of human primary non-small cell lung carcinomas to exposure to the new antitumor polyamine analogue N-1,N-11-bis(ethyl) norspermine. Clin. Cancer Res. 5, 1638-1641
19. Ghoda, L., Basu, H. S., Porter, C. W., Marton, L. J. and Coffino, P. (1992) Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs. Mol. Pharmacol. 42, 302-306
20. He, Y., Suzuki, T., Kashiwagi, K., Kusamaeguchi, K., Shirahata, A. and Igarashi, K. (1994) Correlation between the inhibition of cell growth by bis(ethyl) polyamine analogues and the decrease in the function of mitochondria. Eur. J. Biochem. 221, 391-398
21. 14-bis-(ethyl)-homospermine (BE-4-4-4) on the growth of U-251 MG and SF-188 human brain tumor cells. Int. J. Cancer 48, 873-878
22. Hahm, H. A., Ettinger, D. S., Bowling, K., Hoker, B., Chen, T. L., Zabelina, Y and Casero, R. A. (2002) Phase I study of N-1, N-11- diethylnorspermine in patients with non-small cell lung cancer. Clin. Cancer Res. 8, 684-690
23. Wolff, J. C., Armstrong, D. K., Petting, J. H., Carducci, M. K., Riley, C. D., Bender, J. F., Casero, R. A. and Davidson, N. E. (2003) A phase II study of the polyamine analog N-1, N-11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin. Cancer Res. 9, 5922-5928
24. Martin, B., Posseme, F, Le Barbier, C., Carreaux, F, Carboni, B., Seiler, N., Moulinoux, J. P. and Delcros, J. G. (2002) Z-1,4-diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging: Synthesis and biological evaluation. Bioorganic Med. Chem. 10, 2863-2871
25. Shuto, J. C., Cai, J., Soloway, A. H., Barth, R. F., Adams, D. M., Ji, W. and Tjarks, W. (1999) Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron cature therapy of brain tumors. J. Med. Chem. 42, 1282-1292
26. Cal, J., Soloway, A. H., Barth, R. F., Adams, D. M., Hariharan, J. R., Wyzlic, I. M. and Radcliffe, K. (1997) Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: Synthesis and biological evaluation. J. Med. Chem. 40, 3887-3896
27. Holley, J., Mather, A., Cullis, P., Symons, M. R., Wardman, P., Watt, R. A. and Cohen, G. M. (1992) Uptake and cytotoxicity of novel nitroimidazole- polyamine conjugates in Ehrlich ascites tumour cells. Biochem. Pharmacol. 43, 763-769
28. Lin, P. T., Dance, A. M., Bestwick, C. and Milen, L. (2003) The biological activities of new polyamine derivatives as potential therapeutic agents. Biochem. Soc. Trans. 31, 407-410
29. Bergeron, R. J., McManis, J. S., Franklin, A. M., Yao, H. and Weimar, W. R. (2003) Polyamine-iron chelator conjugate. J. Med. Chem. 46, 5478-5483
30. Nagarajan, M., Xiao, X. S., Antony, S., Kohlhagen, G., Pommier, Y. and Cushman, M, (2003) Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase I inhibitors featuring polyamine side chains on the lactam nitrogen. J. Med. Chem. 46, 5712-5724
31. Kennedy, A. R., Kritchevsky, D. and Shen, W. C. (2003) Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice. Pharm. Res. 20, 1908-1910
32. Soulet, D., Covassin, L., Kaouass, M., Charest-Gaudreault, R., Audette, M. and Poulin, R. (2002) Role of endocytosis in the internalization of spermidine-C-2-BODIPY, a highly fluorescent probe of polyamine transport. Biochem. J. 367, 347-357
33. Belting, M., Mani, K., Jonsson, M., Cheng, F, Sandgren, S., Jonsson, S., Ding, K., Delcros, J. G. and Fransson, L. A. (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells - A pivotal role for nitrosothioi-derived nitric oxide. J. Biol. Chem. 278, 47181-47189
34. Mitchell, J. L. A., Judd, G. G., Bareyal-Leyser, A. and Ling, S. Y. (1994) Feedback repression of polyamine transport is mediated byantizyme in mammalian tissue culture cells. Biochem. J. 299, 19-22
35. He, Y., Suzuki, T., Kashiwagi, K. and Igarashi, K. (1994) Antizyme delays the restoration by spermine of growth of polyamine-deficient cells through its negative regulation of polyamine transport. Biochem. Biophys. Res. Commun. 203, 608-614
36. Murakami, Y., Matsufuji, S., Miyazaki, Y. and Hayashi, S. (1994) Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth. Biochem. J. 304, 183-187
37. Hayashi, S., Murakami, Y. and Matsufuji, S. (1996) Ornithine decarboxylase antizyme - a novel type of regulatory protein. Trends Biochem. Sci. 21, 27-30
38. Sakata, K., Kashiwagi, K. and Igarashi, K. (2000) Properties of a polyamine transporter regulated by antizyme. Biochem. J. 347, 297-303
39. Sakata, K., Fukuchishimogori, T., Kashiwagi, K. and Igarashi, K. (1997) Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport. Biochem. Biophys. Res. Commun. 238, 415-419
40. Matsufuji, S., Matsufuji, T., Miyazaki, Y., Murakami, Y., Atkins, J. F., Gesteland, R. F. and Hayashi, S. (1995) Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 80, 51-60
41. Mitchell, J. L. A., Leyser, A., Holtorff, M. S., Bates, J. S., Frydman, B., Valasinas, A. L., Reddy, V. K. and Marton, L. J. (2002) Antizyme induction by polyamine analogues as a factor in cell growth inhibition. Biochem. J. 366, 663-672
42. Mitchell, J. L. A., Judd, G. G., Leyser, A. and Choe, C.-Y (1998) Osmotic stress induces variation in cellular levels of ODC-antizyme. Biochem. J. 329, 453-459
43. Mitchell, J. L. A. and Judd, G. G. (1998) Antizyme modifications affecting polyamine homeostasis. Biochem. Soc. Trans. 26, 591-595
44. Nilsson, J., Grahn, B. and Heby, O. (2000) Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem. J. 346, 699-704
45. Valasinas, A., Sarkar, A., Reddy, V. K., Marton, L. J., Basu, H. S. and Frydman, B. (2001) Conformationally restricted analogues of N-1NW-14- bisethylhomospermine (BE-4-4-4): Synthesis and growth inhibitory effects on human prostate cancer cells. J. Med. Chem. 44, 390-403
46. Ivanov, I. P., Gesteland, R. F. and Atkins, J. F. (1998) A second mammalian antizyme: conservation of programmed ribosomal frameshifting. Genomics 52, 119-129
47. Ivanov, I. P., Rohrwasser, A., Terreras, D. A., Gesteland, R. F. and Atkins, J. F. (2000) Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3. Proc. Nat. Acad. Sci. U.S.A. 97, 4808-4813
48. Minocha, S. C., Minocha, R. and Robie, C. A. (1990) High-performance liquid Chromatographic method for the determination of dansyl-polyamines. J. Chromatogr. 511, 177-183
49. Byers, T. L. and Pegg, A. E. (1989) Properties and physiological function of the polyamine transport system. Am. J. Physiol. 257, C545-C553
50. Mitchell, J. L. A., Diveley, Jr, R. R. and Bareyal-Leyser, A. (1992) Feedback repression of polyamine uptake into mammalian cells requires active protein synthesis. Biochem. Biophys. Res. Commun. 186, 81-88
51. Carlisle, D. L., Devereux, W. L., Hacker, A., Woster, P. M. and Casero, R. A. (2002) Growth status significantly affects the response of human lung cancer cells to antitumor polyamine-analogue exposure. Clin. Cancer Res. 8, 2684-2689
52. Koike, C., Chao, D. T. and Zetter, B. R. (1999) Sensitivity to polyamine-induced growth arrest correlates with antizyme induction in prostate carcinoma cells. Cancer Res. 59, 6109-6112
53. Jung, M. H., Kim, S. C., Jeon, G. A., Kim, S. H., Kim, Y., Choi, K. S., Park, S. I., Joe, M. K. and Kimm, K. (2000) Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics 69, 281-286
54. Kramer, D. L., Miller, J. T., Bergeron, R. J., Khomutov, R., Khomutov, A. and Porter, C. W. (1993) Regulation of polyamine transport by polyamines and polyamine analogs. J. Cell. Physiol. 155, 399-407
55. Iwata, S., Sato, Y., Asada, M., Takagi, M., Tsujimoto, A., Inaba, T., Yamada, T., Sakamoto, S., Yata, J., Shimogori, T. et al. (1999) Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene 18, 165-172
56. Feith, D. J., Shantz, L. M. and Pegg, A. E. (2001) Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res. 61, 6073-6081
57. Tsuji, T., Todd, R., Meyer, C., Mcbride, J., Liao, P. H., Huang, M. F., Chou, M. Y., Donoff, R. B. and Wong, D. W. (1998) Reduction of ornithine decarboxylase antizyme (Odc-az) level in the 7,12-dimethylbenz(A)anthracene- induced hamster buccal pouch carcinogenesis model, Oncogene 16, 3379-3385
58. Hölttä, E, Hannonen, P., Pispa, J. and Jänne, J. (1973) Effect of methylglyoxal bis(guanylhydrazone) on polyamine metabolism in normal and regenerating rat liver and rat thymus. Biochem. J. 136, 669-676